Search results for: prescribers and at-risk

DEVELOPMENT OF SOCIAL MARKETING CAMPAIGN CONCEPTS FOR PRESCRIBERS AND AT-RISK POPULATIONS

Use of CSMD information can improve patient care and safety by preventing the misuse, abuse, and diversion of prescription-controlled substance drugs while ensuring patients receive the medical care they need. Some of the requirements of the solutions and the Contractor are highlighted below. Please note these requirements are intended to illustrate the State’s current expectations for these solutions.

The equipment would preferably have interoperability capability with federal Risk Evaluation and Mitigation Strategy (REMS) program, with results simultaneously transmitted to the clozapine monitoring registry, the prescriber and the pharmacy.  Integral Care is seeking bids to provide Clozapine Point-of-Care Testing equipment and a software package.

Funding medical provider education and outreach regarding best prescribing practices for opioids consistent with the Guidelines for Prescribing Opioids for Chronic Pain from the U.S. Centers for Disease Control and Prevention, including providers at hospitals (academic detailing). 2. Training for health care providers regarding safe and responsible opioid prescribing, dosing, and tapering patients off opioids. 3.

DMHAS anticipates making up to five (5) awards of up to $425,000 each. 1 Low threshold medication services create access to care by removing traditional barriers such as requirements for abstinence or ongoing counseling, to individuals who are at high risk.

Using accurate and comprehensive data, describe the need in your community for mobile medication services, including data about people who are homeless or at risk of homelessness.

of high risk indicators (e.g. overdose and substance use disorders).